| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.
|
Nat Med
|
2004
|
6.46
|
|
2
|
Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control.
|
PLoS Med
|
2005
|
4.00
|
|
3
|
Protein kinase G from pathogenic mycobacteria promotes survival within macrophages.
|
Science
|
2004
|
3.16
|
|
4
|
Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin.
|
Cell
|
2007
|
2.51
|
|
5
|
Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.
|
J Immunol
|
2004
|
2.47
|
|
6
|
Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis.
|
Infect Immun
|
2003
|
1.91
|
|
7
|
Pulmonary necrosis resulting from DNA vaccination against tuberculosis.
|
Infect Immun
|
2003
|
1.81
|
|
8
|
PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence.
|
PLoS One
|
2008
|
1.79
|
|
9
|
Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.
|
Tuberculosis (Edinb)
|
2005
|
1.73
|
|
10
|
Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice.
|
Infect Immun
|
2006
|
1.63
|
|
11
|
Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin.
|
Immunology
|
2004
|
1.61
|
|
12
|
Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
|
Vaccine
|
2006
|
1.55
|
|
13
|
Differential production of systemic and intralesional gamma interferon and interleukin-10 in nodular and ulcerative forms of Buruli disease.
|
Infect Immun
|
2004
|
1.34
|
|
14
|
Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.
|
Infect Immun
|
2007
|
1.33
|
|
15
|
Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCG.
|
Infect Immun
|
2006
|
1.32
|
|
16
|
Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice.
|
J Clin Invest
|
2009
|
1.29
|
|
17
|
A novel and more sensitive loop-mediated isothermal amplification assay targeting IS6110 for detection of Mycobacterium tuberculosis complex.
|
Microbiol Res
|
2009
|
1.29
|
|
18
|
Mycobacterium tuberculosis with disruption in genes encoding the phosphate binding proteins PstS1 and PstS2 is deficient in phosphate uptake and demonstrates reduced in vivo virulence.
|
Infect Immun
|
2005
|
1.18
|
|
19
|
Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults.
|
Clin Diagn Lab Immunol
|
2003
|
1.11
|
|
20
|
Members of the 30- to 32-kilodalton mycolyl transferase family (Ag85) from culture filtrate of Mycobacterium avium subsp. paratuberculosis are immunodominant Th1-type antigens recognized early upon infection in mice and cattle.
|
Infect Immun
|
2006
|
1.11
|
|
21
|
Validation of a medium-throughput method for evaluation of intracellular growth of Mycobacterium tuberculosis.
|
Clin Vaccine Immunol
|
2010
|
1.06
|
|
22
|
Development and validation of a triplex real-time PCR for rapid detection and specific identification of M. avium sub sp. paratuberculosis in faecal samples.
|
Vet Microbiol
|
2008
|
1.06
|
|
23
|
Buruli ulcer.
|
Hum Vaccin
|
2011
|
1.02
|
|
24
|
Functional characterization of in vivo effector CD4(+) and CD8(+) T cell responses in acute Toxoplasmosis: an interplay of IFN-gamma and cytolytic T cells.
|
Vaccine
|
2010
|
0.99
|
|
25
|
Induction of in vivo functional Db-restricted cytolytic T cell activity against a putative phosphate transport receptor of Mycobacterium tuberculosis.
|
J Immunol
|
2004
|
0.99
|
|
26
|
Clinical value of IS6110-based loop-mediated isothermal amplification for detection of Mycobacterium tuberculosis complex in respiratory specimens.
|
J Infect
|
2013
|
0.97
|
|
27
|
Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boosting.
|
PLoS Negl Trop Dis
|
2008
|
0.96
|
|
28
|
Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis.
|
J Infect Dis
|
2004
|
0.95
|
|
29
|
Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation.
|
Vaccine
|
2002
|
0.94
|
|
30
|
Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c).
|
Vaccine
|
2008
|
0.94
|
|
31
|
Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in mice.
|
Infect Immun
|
2012
|
0.93
|
|
32
|
Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
|
PLoS One
|
2012
|
0.92
|
|
33
|
Mucosal prime-boost vaccination for tuberculosis based on TLR triggering OprI lipoprotein from Pseudomonas aeruginosa fused to mycolyl-transferase Ag85A.
|
Immunol Lett
|
2007
|
0.92
|
|
34
|
Vaccination against paratuberculosis.
|
Expert Rev Vaccines
|
2008
|
0.92
|
|
35
|
Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3.
|
Immunology
|
2006
|
0.91
|
|
36
|
A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in mice.
|
Infect Immun
|
2007
|
0.91
|
|
37
|
Mice genetically inactivated in interleukin-17A receptor are defective in long-term control of Mycobacterium tuberculosis infection.
|
Immunology
|
2013
|
0.91
|
|
38
|
Development of luminescent Mycobacterium avium subsp. paratuberculosis for rapid screening of vaccine candidates in mice.
|
Infect Immun
|
2006
|
0.90
|
|
39
|
Partial reconstitution of the CD4+-T-cell compartment in CD4 gene knockout mice restores responses to tuberculosis DNA vaccines.
|
Infect Immun
|
2006
|
0.89
|
|
40
|
Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovis.
|
Infect Immun
|
2002
|
0.89
|
|
41
|
Antigen discovery: a postgenomic approach to paratuberculosis diagnosis.
|
Proteomics
|
2007
|
0.87
|
|
42
|
An update on vaccines for tuberculosis - there is more to it than just waning of BCG efficacy with time.
|
Expert Opin Biol Ther
|
2012
|
0.87
|
|
43
|
Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis.
|
EMBO Mol Med
|
2011
|
0.87
|
|
44
|
DNA vaccines against mycobacterial diseases.
|
Expert Rev Vaccines
|
2009
|
0.86
|
|
45
|
Genotyping and strain distribution of Mycobacterium avium subspecies hominissuis isolated from humans and pigs in Belgium, 2011-2013.
|
Euro Surveill
|
2016
|
0.85
|
|
46
|
Creating hybrid proteins by insertion of exogenous peptides into permissive sites of a class A beta-lactamase.
|
FEBS J
|
2008
|
0.85
|
|
47
|
Genetic resistance of mice to Mycobacterium paratuberculosis is influenced by Slc11a1 at the early but not at the late stage of infection.
|
Infect Immun
|
2008
|
0.84
|
|
48
|
Chronic intranasal administration of mould spores or extracts to unsensitized mice leads to lung allergic inflammation, hyper-reactivity and remodelling.
|
Immunology
|
2007
|
0.84
|
|
49
|
Increased pulmonary tumor necrosis factor alpha, interleukin-6 (IL-6), and IL-17A responses compensate for decreased gamma interferon production in anti-IL-12 autovaccine-treated, Mycobacterium bovis BCG-vaccinated mice.
|
Clin Vaccine Immunol
|
2010
|
0.83
|
|
50
|
DNA vaccination for the priming of neutralizing antibodies against non-immunogenic STa enterotoxin from enterotoxigenic Escherichia coli.
|
Vaccine
|
2005
|
0.83
|
|
51
|
Immunogenicity and protective efficacy of DNA vaccines encoding MAP0586c and MAP4308c of Mycobacterium avium subsp. paratuberculosis secretome.
|
Vaccine
|
2008
|
0.82
|
|
52
|
Comparison of IFN-gamma responses to mycobacterial antigens as markers of response to BCG vaccination.
|
Tuberculosis (Edinb)
|
2008
|
0.82
|
|
53
|
Pertussis serodiagnosis in Belgium from 1990 to 2009.
|
Clin Vaccine Immunol
|
2011
|
0.81
|
|
54
|
Evaluation of the immunogenicity of pBudCE4.1 plasmids encoding mycolyl-transferase Ag85A and phosphate transport receptor PstS-3 from Mycobacterium tuberculosis.
|
Vaccine
|
2005
|
0.81
|
|
55
|
Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice.
|
PLoS One
|
2013
|
0.81
|
|
56
|
Synthesis and antimycobacterial activity of analogues of the bioactive natural products sampangine and cleistopholine.
|
Eur J Med Chem
|
2013
|
0.80
|
|
57
|
Immunogenicity of eight Mycobacterium avium subsp. paratuberculosis specific antigens in DNA vaccinated and Map infected mice.
|
Vet Immunol Immunopathol
|
2011
|
0.80
|
|
58
|
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine co-expressing pro-apoptotic caspase-3.
|
Vaccine
|
2008
|
0.80
|
|
59
|
DNA vaccines against tuberculosis.
|
Expert Opin Biol Ther
|
2014
|
0.80
|
|
60
|
Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis.
|
Vaccine
|
2012
|
0.80
|
|
61
|
Novel bacterial delivery system with attenuated Salmonella typhimurium carrying plasmid encoding Mtb antigen 85A for mucosal immunization: establishment of proof of principle in TB mouse model.
|
Ann N Y Acad Sci
|
2005
|
0.79
|
|
62
|
T cell reactivity against mycolyl transferase antigen 85 of M. tuberculosis in HIV-TB coinfected subjects and in AIDS patients suffering from tuberculosis and nontuberculous mycobacterial infections.
|
Clin Dev Immunol
|
2010
|
0.79
|
|
63
|
Culture filtrate specific H-2(b) restricted CD8+ T cells activated in vivo by Mycobacterium tuberculosis or bovis BCG recognize a restricted number of immunodominant peptides.
|
Immunol Lett
|
2002
|
0.78
|
|
64
|
Induction of the specific allergic immune response is independent of proteases from the fungus Alternaria alternata.
|
Eur J Immunol
|
2013
|
0.78
|
|
65
|
Biological evaluation of bisbenzaldehydes against four Mycobacterium species.
|
Eur J Med Chem
|
2013
|
0.78
|
|
66
|
Cloning, sequencing, and cell surface expression pattern of bovine immunoreceptor NKG2D and adaptor molecules DAP10 and DAP12.
|
Immunogenetics
|
2007
|
0.78
|
|
67
|
1,2,3,4,8,9,10,11-octahydrobenzo[j]phenanthridine-7,12-diones as new leads against Mycobacterium tuberculosis.
|
J Med Chem
|
2014
|
0.78
|
|
68
|
Use of Strep-tag II for rapid detection and purification of Mycobacterium tuberculosis recombinant antigens secreted by Streptomyces lividans.
|
J Microbiol Methods
|
2013
|
0.76
|
|
69
|
Biochemical and immunological characterization of a cpn60.1 knockout mutant of Mycobacterium bovis BCG.
|
Microbiology
|
2010
|
0.76
|
|
70
|
Targeting the deep lungs, Poloxamer 407 and a CpG oligonucleotide optimize immune responses to Mycobacterium tuberculosis antigen 85A following pulmonary delivery.
|
Eur J Pharm Biopharm
|
2012
|
0.76
|
|
71
|
M.tuberculosis mutants lacking oxygenated mycolates show increased immunogenicity and protective efficacy as compared to M. bovis BCG vaccine in an experimental mouse model.
|
PLoS One
|
2013
|
0.76
|
|
72
|
Inflammatory Properties and Adjuvant Potential of Synthetic Glycolipids Homologous to Mycolate Esters of the Cell Wall of Mycobacterium tuberculosis.
|
J Innate Immun
|
2016
|
0.75
|
|
73
|
Correction: Capture-Recapture Estimators in Epidemiology with Applications to Pertussis and Pneumococcal Invasive Disease Surveillance.
|
PLoS One
|
2016
|
0.75
|
|
74
|
Characterization of new Alternaria alternata--specific rat monoclonal antibodies.
|
Mycopathologia
|
2011
|
0.75
|
|
75
|
Straightforward palladium-mediated synthesis and biological evaluation of benzo[j]phenanthridine-7,12-diones as anti-tuberculosis agents.
|
Eur J Med Chem
|
2011
|
0.75
|